OakChart

NovoCure Ltd

NVCRHealthcare·Medical Devices·United Kingdom·Small·NASD·Nov 11 • 3:59 PM ET

11.99+0.18 (1.52%)
2026-11-12 07:04 CET
Market cap
1,401.82 USD m
Revenue, TTM
725.39 USD m
Net income, TTM
-121.73 USD m
Free cash flow, TTM
-24.61 USD m
EPS diluted, TTM
-1.07
P/E
-
Compare

Price

NVCR against its 20, 50 and 200-day averages
2050200beat
Patternshover a marker to name it
12.5015.0017.5020.004.5M8.9MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26NVCRclose 11.9920-day 13.9250-day 15.07200-day 14.8011.9952w high

44.1% under the 52-week high of 21.45 on 24 Jul 2026. 52-week low 9.82 on 5 Feb 2026. Last 15 sessions, 35.4% high to low

Volume 1.03× normal · the line is the 50-bar volume average

Profile

NVCR
52-week range, 19% of the way up
9.8221.45

NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, the United Kingdom.

IndexRUT
Employees1605
IPOOct 02, 2015
Beta1.10
ATR, 14d0.86
Rel volume1.03
Short float12.29%
Insider own10.11%
Inst own90.74%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap1.40B
Enterprise Value1.16B
Income-121.73M
Sales725.39M
Book/sh3.00
Cash/sh4.05
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees1605
IPOOct 02, 2015

Ratios

P/E-
Forward P/E-
PEG-
P/S1.93
P/B4.00
P/C2.96
P/FCF-
EV/EBITDA-
EV/Sales1.60
Quick Ratio2.34
Current Ratio2.49
Debt/Eq0.66
LT Debt/Eq0.59
Option/ShortYes / Yes

Earnings

EPS (ttm)-1.07
EPS next Y-0.76
EPS next Q-0.21
EPS this Y13.61%
EPS next Y27.72%
EPS next 5Y32.91%
EPS past 3/5Y-11.40% -
Sales past 3/5Y6.81% 5.80%
EPS Y/Y TTM33.87%
Sales Y/Y TTM12.94%
EPS Q/Q73.15%
Sales Q/Q15.67%
EarningsOct 29 BMO
EPS/Sales Surpr.61.69% 6.10%

Ownership

Insider Own10.11%
Insider Trans-0.47%
Inst Own90.74%
Inst Trans6.18%
ROA-11.12%
ROE-35.18%
ROIC-21.85%
Gross Margin77.02%
Oper. Margin-17.17%
Profit Margin-16.78%
SMA20-13.84%
SMA50-20.46%
SMA200-18.98%
Trades-

Technical

Shs Outstand116.91M
Shs Float105.09M
Short Float12.29%
Short Ratio8.67
Short Interest12.91M
52W High21.45 -44.10%
52W Low9.82 22.10%
Volatility7.70% 6.06%
ATR (14)0.86
RSI (14)33.79
Beta1.10
Rel Volume1.03
Avg Volume1.49M
Volume1,531,734

Performance

Perf Week-17.93%
Perf Month-16.15%
Perf Quarter-31.01%
Perf Half Y-33.76%
Perf YTD-7.27%
Perf Year1.10%
Perf 3Y7.73%
Perf 5Y-89.27%
Perf 10Y33.97%
Recom1.80
Target Price22.80
Prev Close11.81
Price11.99
Change %1.52%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Jul 13, 2026ResumedJJP MorganNeutral$17+41.8%
Jul 25, 2025DowngradeWWells FargoOverweight → Equal Weight$14.50+20.9%
Jul 08, 2025InitiatedLLadenburg ThalmannBuy$30+150.2%
Dec 02, 2024UpgradeEEvercore ISIIn-line → Outperform$18 → $30+150.2%
Oct 16, 2024UpgradeHH.C. WainwrightNeutral → Buy$24 → $30+150.2%
Nov 20, 2023ResumedJJP MorganNeutral$15+25.1%
Aug 28, 2023DowngradeHH.C. WainwrightBuy → Neutral$85 → $25+108.5%
Aug 08, 2023UpgradePPiper SandlerNeutral → Overweight$45+275.3%
Aug 04, 2023InitiatedSSVB SecuritiesOutperform$51+325.4%
Jul 31, 2023UpgradeEEvercore ISIUnderperform → In-line$33+175.2%

Peers

Mkt cap
TickerCompanyMkt cap
DCTHDelcath Systems Inc757.34M
IRTCiRhythm Holdings Inc2.98B
PROFProfound Medical Corp287.55M
ARAYAccuray Inc9.60M
MDTMedtronic Plc129.98B
ANGOAngiodynamic Inc522.32M
CATXPerspective Therapeutics Inc99.65M
BSXBoston Scientific Corp65.41B
SRTSSensus Healthcare Inc56.13M
ICCMIcecure Medical Ltd2.55M

Insider trading

latest 14 of 36
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
CHRISTOPH BRACKMANNOfficerNov 09 '26Proposed Sale12.867,34394,446Nov 09 04:07 PM
Puri Michal NathChief Human Resources OfficerNov 02 '26Sale13.246608,738202,567Nov 04 04:05 PM
NICOLAS LEUPINOfficerJul 23 '26Proposed Sale15.5739,088608,600Jul 23 04:21 PM
Leonard Frank XChief Executive OfficerJun 04 '26Sale17.9334,273614,635459,520Jun 05 04:28 PM
FRANCIS LEONARDOfficerJun 04 '26Proposed Sale17.9334,273614,635Jun 04 05:41 PM
LEUNG GABRIELDirectorJun 02 '26Sale15.772,94546,44589,499Jun 03 04:54 PM
Stafford KristinDirectorJun 02 '26Sale15.772,94546,44511,324Jun 03 04:53 PM
Ocean Allyson JDirectorJun 02 '26Sale15.772,94546,44511,324Jun 03 04:53 PM
Scannell Timothy JDirectorJun 02 '26Sale15.772,94546,44514,288Jun 03 04:53 PM
HILLEMAN JERYL LDirectorJun 02 '26Sale15.772,94546,44513,861Jun 03 04:53 PM
VERNON W ANTHONYDirectorJun 02 '26Sale15.772,94546,445197,657Jun 03 04:52 PM
Hung DavidDirectorJun 02 '26Sale15.772,94546,44520,465Jun 03 04:52 PM
VERNON W ANTHONYDirectorApr 28 '26Option Exercise11.3921,500244,885200,602Apr 28 04:27 PM
Leupin NicolasFormer Chief Medical OfficerMar 04 '26Sale13.311,10014,636102,979Mar 05 04:33 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VBKVanguard Morningstar Small-Cap Growth ETFAUM: 22.34B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
IBBiShares Biotechnology ETFAUM: 11.36B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B
IHIiShares U.S. Medical Devices ETFAUM: 4.07B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-10-29-0.090-0.235-0.090193.4182.287
2026Q22026-07-23-0.130-0.332-0.135183.58172.446
2026Q12026-04-30-0.620-0.512-0.623174.06167.777
2025Q42026-02-26-0.220-0.411-0.218174.35174.47
2025Q32025-10-30-0.330-0.420-0.333167.2158.948
2025Q22025-07-24-0.360-0.384-0.360158.81154.168
2025Q12025-04-24-0.310-0.464-0.311154.99146.947
2024Q42025-02-27-0.610-0.344-0.608161.27161.37
2024Q32024-10-30-0.280-0.334-0.282155.1143.957
2024Q22024-07-25-0.310-0.403-0.310150.36135.837
2024Q12024-05-02-0.360-0.420-0.361138.5131.447
2023Q42024-02-22-0.450-0.521-0.440133.78133.87
2023Q32023-10-26-0.460-0.525-0.464127.32128.756
2023Q22023-07-27-0.540-0.500-0.540126.05124.255
2023Q12023-05-04-0.500-0.323-0.502122.18127.777
2022Q42023-02-23-0.360-0.303-0.355128.43128.48

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-0.070-0.113-0.074351.3351.3
2020FY0.1800.2620.182494.37494.4
2021FY-0.560-0.416-0.564535.03535
2022FY-0.880-0.824-0.884537.84537.8
2023FY-1.950-2.024-1.946509.34509.3
2024FY-1.560-1.296-1.564605.22605.2
2025FY-1.220-1.401-1.220655.35655.4
2026FY--1.054--740.81
2027FY--0.762--799.34
2028FY--0.368--891.11
2029FY-1.900--1,407
2030FY-4.530--1,740

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-09550189.8186.98191.3
2026Q4S2026-11-06550189.8187191.3
2026Q4S2026-10-31650190.19187192.14
2026Q4S2026-10-29750189.72186.9192.14
2026Q4S2026-10-06700185.8180.7192.14
2026Q4S2026-07-29750185.8180.7192.14
2026Q4S2026-07-28750185.78180.7192
2026Q4S2026-07-23650184.75180.7186.9
2026Q4S2026-07-20600181.02177.3187
2026Q4S2026-07-15700180.78177.3187
2026Q4S2026-07-14701180.78177.3187
2026Q4S2026-06-17722180.78177.3187
2026Q4S2026-05-12722180.79177.3187
2026Q4S2026-05-10732180.79177.3187

Estimate history

EPS, annual-0.696-0.692-0.0740.182-0.564-0.884-1.946-1.564-1.222-1.0658
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.282-0.608-0.311-0.36-0.333-0.218-0.623-0.135-0.089
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual177.026248.069351.318494.366535.031537.84509.338605.22655.353725.39
Period201720182019202020212022202320242025TTM
Sales, quarterly155.095161.266154.994158.805167.204174.35174.055183.584193.399
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual89.47893.25499.528102.334103.971105.049107.076108.517112.493116.914
Period201720182019202020212022202320242025MRQ
Shares, quarterly108.1108.517111.483111.799111.98112.493115.821116.442116.914
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue725.39655.35605.22509.34537.84535.03494.37351.32248.07
Cost of Goods Sold Incl. D&A166.72165.17136.18127.53114.26114.24106.0988.2882.58
Gross Profit558.67490.18469.05381.80423.58420.79388.27263.04165.49
Selling, General and Administrative Excl. Other683.21642.27636.58607.96512.50464.49357.46263.63199.16
Research and Development228.79224.54209.37220.99206.09201.30132.0179.0050.57
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-124.55-152.09-167.54-226.16-88.91-43.6930.81-0.59-33.67
Interest Expense6.0022.2211.664.918.118.8418.0514.6416.91
Unusual Expense0.001.712.966.710.610.640.410.330.00
Net Income Before Taxes-130.54-136.25-131.16-191.74-81.85-52.0818.10-8.82-45.94
Income Taxes-8.81-0.0237.4715.3010.696.28-1.71-1.5917.62
Consolidated Net Income-121.73-136.23-168.63-207.04-92.53-58.3519.81-7.23-63.56
Net Income From Continuing Operations-121.73-136.23-168.63-207.04-92.53-58.3519.81-7.23-63.56
Net Income-121.73-136.23-168.63-207.04-92.53-58.3519.81-7.23-63.56
EPS (Recurring)-1.04-1.21-1.54-1.90-0.88-0.560.18-0.07-0.69
EPS (Basic, Before Extraordinaries)-1.07-1.22-1.56-1.95-0.88-0.560.20-0.07-0.69
EPS (Diluted)-1.07-1.22-1.56-1.95-0.88-0.560.18-0.07-0.69
EBITDA-107.48-137.44-156.30-215.19-78.29-33.4439.967.81-24.67
Non-Operating Income (Expense)0.0039.7751.0046.0415.791.105.756.734.64
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense83.0082.82126.4391.3384.4969.2859.8238.2631.48
Price To Earnings Ratio------951.82--
Price To Sales Ratio2.572.205.313.1214.2714.5138.1123.3212.39
Gross Margin77.0274.8077.5074.9678.7678.6578.5474.8766.71
Operating Margin-17.17-23.21-27.68-44.40-16.53-8.176.23-0.17-13.57
Net Margin-16.78-20.79-27.86-40.65-17.20-10.914.01-2.06-25.62
Shares Outstanding116.91112.49108.52107.08105.05103.97102.3399.5393.25
Market Capitalization1,401.821,401.823,224.391,595.437,698.087,794.7317,614.958,340.123,114.11

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue193.40183.58174.06174.35167.20158.81154.99161.27
Cost of Goods Sold Incl. D&A44.5341.1138.9342.1644.7341.4738.5232.51
Gross Profit148.87142.48135.13132.19122.47117.33116.47128.75
Selling, General and Administrative Excl. Other155.04153.04202.55172.59158.50156.85154.34191.10
Research and Development58.1051.4558.3460.9154.0355.8353.7851.21
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-6.17-10.56-67.42-40.39-36.02-39.52-37.87-62.35
Interest Expense1.711.891.840.56----
Unusual Expense0.000.000.000.000.000.000.000.95
Net Income Before Taxes-7.88-12.45-69.26-40.95-30.02-34.98-30.30-55.21
Income Taxes2.563.211.88-16.457.255.164.0210.72
Consolidated Net Income-10.44-15.66-71.14-24.50-37.27-40.14-34.32-65.92
Net Income From Continuing Operations-10.44-15.66-71.14-24.50-37.27-40.14-34.32-65.92
Net Income-10.44-15.66-71.14-24.50-37.27-40.14-34.32-65.92
EPS (Recurring)-0.09-0.13-0.62-0.22-0.33-0.36-0.31-0.60
EPS (Basic, Before Extraordinaries)-0.09-0.14-0.62-0.22-0.33-0.36-0.31-0.61
EPS (Diluted)-0.09-0.14-0.62-0.22-0.33-0.36-0.31-0.61
EBITDA-1.75-6.25-63.30-36.17-32.36-36.08-34.54-59.25
Non-Operating Income (Expense)0.000.000.000.006.004.547.578.10
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense13.8113.4449.785.9723.1620.6523.3549.58
Price To Sales Ratio2.572.511.842.212.253.153.165.34
Gross Margin76.9877.6177.6375.8273.2573.8875.1579.84
Operating Margin-3.19-5.75-38.73-23.17-21.54-24.89-24.43-38.66
Net Margin-5.40-8.53-40.87-14.05-22.29-25.28-22.14-40.88
Shares Outstanding116.91116.44115.82112.49111.98111.80111.48108.52
Market Capitalization1,401.821,754.691,240.351,447.931,444.441,984.451,958.693,224.39

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments457.52962.20912.36969.93938.51854.08328.19248.01185.44
Short Term Receivables115.3598.6471.7893.4197.41100.4763.9647.1934.50
Inventories41.1135.0938.1529.3824.4327.4223.7022.5522.02
Other Current Assets32.7610.6512.1118.8113.1817.4824.113.613.17
Total Current Assets646.731,106.581,034.411,111.531,073.53999.44439.95321.37245.13
Net Property, Plant & Equipment147.00119.5997.7068.9653.8841.6334.6015.3718.07
Total Investments and Advances0.000.000.000.000.000.000.000.000.00
Other Assets10.6014.6214.0211.1612.0910.914.903.062.10
Total Assets804.331,240.781,146.131,191.651,139.491,051.98479.45339.79265.30
Short Term Debt Incl. Current Port. of LT Debt11.66566.078.225.806.686.484.630.000.00
Accounts Payable122.23105.0994.3985.2072.6053.6536.9226.7117.21
Income Tax Payable-22.819.138.665.805.3412.0112.269.11
Other Current Liabilities89.3462.4167.3759.1257.5248.1432.7425.5923.89
Total Current Liabilities223.23756.38179.12158.78142.60113.6186.3164.5650.20
Long Term Debt236.69117.27596.24584.27575.21444.20163.56149.2797.34
Provision for Risks Charges3.946.968.284.484.705.473.872.792.70
Deferred Tax Liabilities-------0.12-
Other Liabilities0.000.000.002.956.4912.187.9110.801.49
Total Liabilities463.86880.61783.63750.48729.00575.46261.66227.53151.73
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity340.47360.18362.50441.17410.49476.53217.79112.26113.56
Total Shareholders Equity340.47360.18362.50441.17410.49476.53217.79112.26113.56
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity340.47360.18362.50441.17410.49476.53217.79112.26113.56
Total Liabilities & Stockholders Equity804.331,240.781,146.131,191.651,139.491,051.98479.45339.79265.30
Book Value Per Share3.033.323.394.203.954.662.191.201.27
Tangible Book Value Per Share3.033.323.394.203.954.662.191.201.27
Full-Time Employees1,6051,4881,4531,3201,1671,023782598495
Price to Book Ratio4.008.934.0517.2819.0237.1638.5127.8115.47
Return on Assets-13.32-14.13-17.71-7.94-5.332.59-1.77-21.01-22.53
Return on Equity-38.89-46.67-51.52-21.73-13.165.71-4.38-56.29-48.19
Return on Invested Capital-23.60-35.32-21.60-9.02-5.922.15-1.90-24.30-29.24
Quick Ratio2.711.425.566.827.368.564.824.634.44
Current Ratio2.901.465.787.007.538.805.104.984.88

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-121.73-136.23-168.63-207.04-92.53-58.3519.81-7.23-63.56
Depreciation17.0714.6511.2310.9710.6210.259.158.469.01
Other Funds (Non Cash)110.4987.67135.3293.18103.12101.8878.7149.7241.27
Funds from Operations5.83-33.91-22.07-102.9021.2153.78107.6750.95-13.28
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-6.55-15.13-4.3029.569.5828.98-8.52-24.3311.41
Cash from Operating Activities-0.72-49.03-26.37-73.3430.7982.7699.1526.62-1.86
Capital Expenditures-23.89-26.65-42.85-27.09-21.36-24.17-14.97-10.48-6.71
Net Assets From Acquisitions0.000.000.000.000.000.000.000.00-
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.00-
Purchase or Sale of Investments338.34463.92-97.39211.24-118.60-120.66-457.88-41.181.22
Purchase of Investments-526.66-821.08-875.39-1,003.74-1,297.89-1,078.66-607.88-461.84-253.78
Sale Or Maturity of Investments865.001,285.00778.001,214.981,179.29958.00150.00420.66255.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities314.46437.28-140.24184.15-139.96-144.83-472.85-51.67-5.49
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock10.189.776.3115.8015.5225.7331.8061.7120.30
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock10.189.776.3115.8015.5225.7331.8061.7120.30
Proceedsfrom Stock Options3.613.664.154.425.224.553.372.471.83
Issuance or Reduction of Debt, Net-560.95-460.9784.01-0.01-0.03-0.03408.41-0.0349.07
Change in Long Term Debt-560.95-460.9784.01-0.01-0.03-0.03408.41-0.0349.07
Issuance of Long Term Debt0.0099.9896.920.000.000.00558.440.00149.15
Reduction of Long Term Debt-560.95-560.95-12.91-0.01-0.03-0.03-150.03-0.03-100.08
Net Financing Active Other Cash Flow-0.70-0.150.000.000.000.000.000.000.00
Other Financing Activities Uses-0.70-0.150.000.000.000.000.000.000.00
Cash from Financing Activities-551.47-451.3490.3115.7915.4925.70440.2161.6869.37
Exchange Rate Effect-0.070.39-0.170.13-0.10-0.190.250.030.03
Net Change in Cash-237.80-62.70-76.47126.73-93.78-36.5666.7636.6662.04
Free Cash Flow-24.61-75.68-69.22-100.439.4358.5984.1816.14-8.58
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow----814.09132.55223.81507.85-
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments473.58450.48441.80457.521,036.02914.03
Short Term Receivables108.2699.1393.27115.3585.2389.92
Inventories40.6042.2243.4641.1139.1040.21
Other Current Assets51.0746.6953.1332.7639.5039.14
Total Current Assets673.52638.52631.66646.731,199.851,083.30
Net Property, Plant & Equipment144.09145.74145.06147.00148.93147.01
Total Investments and Advances0.000.000.000.000.000.00
Other Assets11.1010.9311.2010.6012.4115.56
Total Assets828.71795.19787.93804.331,361.191,245.88
Short Term Debt Incl. Current Port. of LT Debt25.000.000.0011.66560.62559.79
Accounts Payable145.92130.73127.24122.23118.92103.68
Other Current Liabilities99.7489.9890.3489.3496.4686.17
Total Current Liabilities270.66220.71217.58223.23776.01749.63
Long Term Debt206.55233.42234.94236.69237.32140.46
Provision for Risks Charges0.882.974.693.946.516.32
Other Liabilities0.000.000.000.000.020.02
Total Liabilities478.10457.10457.21463.861,019.86896.43
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity350.61338.09330.72340.47341.33349.44
Total Shareholders Equity350.61338.09330.72340.47341.33349.44
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity350.61338.09330.72340.47341.33349.44
Total Liabilities & Stockholders Equity828.71795.19787.93804.331,361.191,245.88
Book Value Per Share3.002.902.863.033.053.13
Tangible Book Value Per Share3.002.902.863.033.053.13
Full-Time Employees---1,605--
Price to Book Ratio4.005.313.604.244.135.48
Return on Assets-11.12-14.56-16.99-13.32-13.75-13.91
Return on Equity-35.18-43.22-49.96-38.89-50.60-48.07
Return on Invested Capital-1.87-2.74-12.58-4.24-6.44-8.19
Quick Ratio2.342.702.702.711.501.39
Current Ratio2.492.892.902.901.551.45

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-10.44-15.66-71.14-24.50-37.27-40.14
Depreciation4.424.314.124.223.663.44
Other Funds (Non Cash)16.6915.1761.5817.0524.0421.48
Funds from Operations10.683.82-5.43-3.24-9.57-15.22
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital11.994.31-8.08-14.7730.14-0.72
Cash from Operating Activities22.678.13-13.52-18.0020.57-15.94
Capital Expenditures-6.92-6.92-5.15-4.90-5.66-5.49
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments-16.320.5412.90341.2277.0941.47
Purchase of Investments-116.32-94.46-97.10-218.78-107.91-378.53
Sale Or Maturity of Investments100.0095.00110.00560.00185.00420.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-23.24-6.387.75336.3371.4435.99
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock3.644.550.391.600.542.39
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock3.644.550.391.600.542.39
Proceedsfrom Stock Options0.002.090.001.520.002.14
Issuance or Reduction of Debt, Net0.000.000.00-560.9599.980.00
Change in Long Term Debt0.000.000.00-560.9599.980.00
Issuance of Long Term Debt0.000.000.000.0099.980.00
Reduction of Long Term Debt0.000.000.00-560.950.000.00
Net Financing Active Other Cash Flow0.000.00-0.56-0.150.000.00
Other Financing Activities Uses0.000.00-0.56-0.150.000.00
Cash from Financing Activities3.644.55-0.17-559.49100.522.39
Exchange Rate Effect0.15-0.01-0.13-0.08-0.020.27
Net Change in Cash3.226.29-6.07-241.25192.5022.70
Free Cash Flow15.751.22-18.67-22.9014.92-21.42

Revenue breakdown

Surgical & Medical Instruments & Apparatus2024: 605.22M 2025: 655.35M
China2024: 17.39M 2025: 19.44M
France2024: 55.73M 2025: 76.19M
Germany2024: 65.26M 2025: 79.41M
Japan2024: 32.57M 2025: 37.79M
Other International Markets2024: 42.47M 2025: 56.90M
United States2024: 391.80M 2025: 385.63M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3012.29%12.9M105.1M1.44M
2026-10-1512.25%12.8M104.7M1.44M
2026-09-3010.67%11.2M104.7M1.41M
2026-09-1511.27%11.8M104.7M1.55M
2026-08-3110.31%10.8M104.7M1.64M
2026-08-148.76%9.2M104.7M1.63M
2026-07-319.69%10.1M104.7M1.79M
2026-07-1511.01%11.5M104.1M1.72M
2026-06-3011.42%11.9M104.1M1.63M
2026-06-159.33%9.7M103.4M1.52M
2026-05-298.79%9.2M104.2M1.49M
2026-05-158.20%8.5M104.1M1.72M
2026-04-306.73%7.0M103.5M1.99M
2026-04-158.56%8.7M101.7M1.88M
2026-03-318.84%9.1M102.4M1.93M
2026-03-138.32%8.5M102.4M1.93M
2026-02-278.91%9.1M102.4M2.03M
2026-02-138.83%8.9M100.8M1.82M
2026-01-307.91%8.0M100.8M1.53M
2026-01-157.40%7.4M100.4M1.55M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call8.002.255.700.005.6090.000.000.857-0.0760.004
call9.001.304.900.005.0410.000.000.823-0.0700.005
call10.000.354.200.004.6540.000.000.775-0.0620.006
call11.000.002.900.003.3570.000.000.686-0.0580.007
call12.000.002.701.503.6771.000.000.582-0.1100.007
call13.000.002.352.001.5304.000.000.424-0.0670.007
call14.000.000.500.101.56235.000.000.304-0.0580.007
call15.000.000.150.181.09085.000.000.109-0.0220.003
call16.000.000.950.101.3086060.000.095-0.0230.003
call17.000.000.300.051.5041303.000.085-0.0250.003
call18.000.002.150.051.6825200.000.078-0.0260.003
call19.000.000.650.051.60520.000.000.044-0.0160.002
call20.000.001.650.051.99840.000.000.068-0.0280.002
call21.000.001.350.002.1090.000.000.065-0.0280.002
call22.000.002.150.002.2710.000.000.062-0.0290.002
call23.000.002.000.002.3610.000.000.060-0.0300.002
call24.000.001.500.002.4730.000.000.057-0.0300.002
call25.000.000.900.002.6430.000.000.056-0.0310.002
call26.000.002.000.002.7290.000.000.054-0.0320.002
put8.000.001.700.003.1750.000.00-0.143-0.0750.004
put9.000.001.750.002.5350.000.00-0.177-0.0690.005
put10.000.001.750.001.9400.000.00-0.225-0.0610.006
put11.000.000.750.201.3632.000.00-0.314-0.0570.007
put12.000.001.200.101.6184890.00-0.418-0.1080.007
put13.000.002.500.632.5484380.00-0.576-0.0660.007
put14.000.253.102.102.4274850.00-0.696-0.0560.007
put15.002.154.103.002.7791140.00-0.891-0.0200.003
put16.002.155.801.834.05612.000.00-0.905-0.0220.003
put17.003.106.802.134.3411.000.00-0.915-0.0230.003
put18.004.107.805.184.5985.000.00-0.922-0.0240.003
put19.005.108.800.004.8330.000.00-0.927-0.0250.003
put20.006.109.800.005.0480.000.00-0.932-0.0260.002
put21.007.1010.800.005.2480.000.00-0.935-0.0260.002
put22.008.1011.800.005.4340.000.00-0.938-0.0270.002
put23.009.1012.800.005.6080.000.00-0.940-0.0270.002
put24.0010.1013.800.005.7710.000.00-0.943-0.0280.002
put25.0011.1014.800.005.9260.000.00-0.944-0.0280.002
put26.0012.1015.800.006.0710.000.00-0.946-0.0290.002

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-09144Filing for proposed sale of securities under Rule 144.SEC
2026-11-098-KCurrent report2026-11-09SEC
2026-11-09SCHEDULE 13G/ASEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-10-29S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-10-298-KCurrent report2026-10-29SEC
2026-10-2910-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-018-KCurrent report2026-10-01SEC
2026-09-098-KCurrent report2026-09-02SEC
2026-09-018-KCurrent report2026-09-01SEC
2026-07-23144Filing for proposed sale of securities under Rule 144.SEC
2026-07-238-KCurrent report2026-07-23SEC
2026-07-2310-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-07-014Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-07-014Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-07-014Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-07-014Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-06-308-KCurrent report2026-06-30SEC
2026-06-188-KCurrent report2026-06-18SEC
2026-06-054Statement of changes in beneficial ownership of securities2026-06-03SEC
2026-06-054Statement of changes in beneficial ownership of securities2026-06-03SEC
2026-06-054Statement of changes in beneficial ownership of securities2026-06-04SEC
2026-06-054Statement of changes in beneficial ownership of securities2026-06-03SEC
2026-06-058-KCurrent report2026-06-03SEC
2026-06-054Statement of changes in beneficial ownership of securities2026-06-03SEC
2026-06-054Statement of changes in beneficial ownership of securities2026-06-03SEC
2026-06-054Statement of changes in beneficial ownership of securities2026-06-03SEC
2026-06-054Statement of changes in beneficial ownership of securities2026-06-03SEC
2026-06-054Statement of changes in beneficial ownership of securities2026-06-03SEC
2026-06-04144Filing for proposed sale of securities under Rule 144.SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-11008.74K1
2026-100000
2026-090000
2026-080000
2026-070000
2026-0600939.75K8
2026-050000
2026-040000
2026-03002.02M10
2026-0200255.95K3
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
FMR LLC14.92%
BlackRock, Inc.11.58%
Soleus Capital Management, L.P.8.56%
VANGUARD PORTFOLIO MANAGEMENT LLC5.42%
VANGUARD CAPITAL MANAGEMENT LLC4.23%
MORGAN STANLEY3.90%
STATE STREET CORP2.47%
GEODE CAPITAL MANAGEMENT, LLC2.41%
WELLS FARGO & COMPANY/MN2.18%
Quantinno Capital Management LP1.92%

Funds

Fund% owned
Fidelity Growth Company Fund5.04%
VANGUARD TOTAL STOCK MARKET INDEX FUND3.01%
iShares Russell 2000 ETF2.40%
VANGUARD SMALL-CAP INDEX FUND2.18%
Fidelity Growth Company K6 Fund1.50%
Fidelity Series Growth Company Fund1.33%
VANGUARD SMALL-CAP GROWTH INDEX FUND1.25%
VANGUARD EXTENDED MARKET INDEX FUND1.05%
Fidelity Small Cap Index Fund1.00%
iShares Russell 2000 Growth ETF0.79%

OakChart. NVCR. Cached 15 minutes.